Natco Pharma hits 52-week low on disappointing December earnings

The stock dipped 7% to Rs 620 after the company reported 27 per cent drop in consolidated net profit at Rs 159 crore for the quarter ended December 2018.

Shares of Natco Pharma hit a 52-week low of Rs 620 apiece, down 7 per cent on the BSE in early morning trade, after the company reported 27 per cent drop in consolidated net profit at Rs 159 crore for the quarter ended December 2018 (Q3FY19).  The pharmaceutical company had posted a profit of Rs 217 crore in a year-ago quarter.

Operational revenue declined 1 per cent to Rs 557 crore against Rs 562 crore in the corresponding quarter of previous fiscal. Ebitda (earnings before interest, taxation, depreciation and ammortisation) margin declined to 37.4 per cent from 50.9 per cent